Cargando…
Possible Application of Melatonin in Long COVID
Clinical sequelae and symptoms for a considerable number of COVID-19 patients can linger for months beyond the acute stage of SARS-CoV-2 infection, “long COVID”. Among the long-term consequences of SARS-CoV-2 infection, cognitive issues (especially memory loss or “brain fog”), chronic fatigue, myalg...
Autores principales: | Cardinali, Daniel P., Brown, Gregory M., Pandi-Perumal, Seithikurippu R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687267/ https://www.ncbi.nlm.nih.gov/pubmed/36358996 http://dx.doi.org/10.3390/biom12111646 |
Ejemplares similares
-
Can Melatonin Be a Potential “Silver Bullet” in Treating COVID-19 Patients?
por: Cardinali, Daniel P., et al.
Publicado: (2020) -
Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010) -
Melatonin’s Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights
por: Cardinali, Daniel P, et al.
Publicado: (2022) -
Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration
por: Cardinali, Daniel P., et al.
Publicado: (2020) -
Melatonin in Mitochondrial Dysfunction and Related Disorders
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2011)